UNSPSC 51381900: Nonsteroidal anti inflammatory azoles

Nonsteroidal anti inflammatory drugs made from five membered rings containing a nitrogen atom, called AZOLES.

UNSPSC 51381900 Nonsteroidal anti-inflammatory azoles is a Class code that nominally covers a specific pharmaceutical class, but the recent state and local solicitation activity under this code shows a significant mismatch: the primary documented opportunity is Seminole County, Florida's June 2026 competitive bid for naloxone and safe drug deactivation systems for community health support. Naloxone is an opioid antagonist, not an NSAID or azole compound, and the procurement plainly falls outside the code's stated pharmaceutical scope. The sourcing reflects operational emergency-response and harm-reduction supply chains rather than anti-inflammatory pharmaceutical procurement. No additional recent state and local opportunities under this code are documented in the source material, indicating either sparse activity or systematic miscoding of health-related solicitations.

Seminole County's IFB60459723LAS represents the sole recent documented opportunity under the code. The bid, posted June 30, 2026, with a response deadline of July 26, 2023 (note: a date inconsistency appears in the source), seeks 1,900 units of naloxone and 800 safe drug deactivation systems annually on a fixed-fee basis with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The contract includes a two-year initial term with a one-year renewal option and a three-month probationary period. Bidders must meet E-Verify compliance, drug-free workplace certification, and specified insurance requirements; the procurement may draw FEMA funding and accordingly subjects vendors to federal environmental compliance (Clean Air Act, Federal Water Pollution Control Act) and audit obligations. Given the code-scope mismatch and the single documented opportunity, this code shows little relevant recent state and local procurement activity.